PharMerica Corporation PMC today sent a letter to
Omnicare, Inc. OCR regarding the previously received and rejected
unsolicited conditional proposal from Omnicare to acquire PharMerica for
$15.00 per share in cash, subject to due diligence and regulatory approvals.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
